Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The ASAP Praises Catheter System which Supports Best Practice Aseptic Technique and Helps Improve Healthcare Worker Safety

Published: Tuesday, October 02, 2012
Last Updated: Tuesday, October 02, 2012
Bookmark and Share
BD NexivaTM Closed IV Catheter System designed to help prevent needlestick injuries and minimise blood exposure.

The Association for Aseptic Practice (ASAP) announced today that it endorses BD Nexiva TM Closed IV Catheter System as a best practice medical device that has been designed to address specific problems in aseptic practice; namely, the risk of catheter-related bloodstream infections (CRBSIs).  This system is the first IV catheter system to be recognised as supporting The ASAP and Aseptic Non-Touch Technique (ANTT®) clinical framework.

The ASAP is committed to improving standards of aseptic technique in clinical practice.  Poor standards of aseptic technique can be a major cause of healthcare-acquired infections (HAIs), such as MRSA and MSSA.  The ASAP oversees the understanding and development of ANTT, a unique, widely recognised and adopted standardised approach to aseptic practice which has been shown to considerably help reduce HCAIs.  BD NexivaTM helps to ensure that best aseptic practice is achieved and clinical procedure is not compromised.

Stephen Rowley, Clinical Director, ANTT UK / USA said, our evaluation identified that “BD Nexiva TM design will help promote asepsis and assists in aseptic technique pre and intra-procedure. The design should also help reduce insertion attempts and improve first-stick success. The blood and needle containment systems were also considered to be innovative ways of protecting health care staff.

Used for peripheral venous access, the all-in-one BD NexivaTM system has BD Instaflash™ technology which is designed to reduce insertion attempts and with its innovative blood-containment system limit healthcare workers’ exposure to blood   This safety-engineered system is also designed to reduce needlestick injury by using passive needle-shielding technology that does not compromise the insertion techniques.

Studies in Europe have estimated that the associated costs of CRBSIs may be hundreds of millions of euros. An important feature incorporated into the BD Nexiva™ Closed IV Catheter System is the BD Q-SyteTM Luer Access Split Septum, which offers a straight and unobstructed fluid path, high flow rates, clear visibility and ease of disinfection.  A split septum needle access system has 64-70% lower CRBSI rates than mechanical halves. By eliminating the complexities of mechanical valves, this split-septum device helps reduce the number of places where bacteria may thrive[iv]. In fact, comparison studies found that patients are three times more likely, on average, to develop a CRBSI with mechanical valves versus a split-septum needle-less access system.

Aseptic practice defines the infection control method and precautions taken during invasive clinical procures to prevent the transfer of micro organisms from the healthcare worker, procedure equipment or the immediate environment to the patient.  It is achieved by ensuring the asepsis of key-parts and key-sites.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BD Diagnostics MRSA Assay Receives FDA Clearance
Company receives FDA clearance to market the BD MAX™ MRSA XT Assay for use on the fully-automated BD MAX™ System.
Tuesday, January 14, 2014
BD Diagnostics Receive FDA Clearance for StaphSR Assay
BD has received FDA clearance to market the BD MAX™ StaphSR Assay for use on the fully-automated BD MAX™ System.
Tuesday, December 03, 2013
BD announces award to NHS Supply Chain Framework Agreement
New award to the national framework agreement for Microbiology generates interest.
Monday, December 10, 2012
Nationwide Educational Tour Kicks Off on the Future of Molecular Diagnostics
BD Diagnostics convenes experts to address pressing topics for clinical laboratory professionals. Focus will be on the growing role of molecular diagnostics in women’s health, as well as advances in its implementation in the clinical laboratory.
Monday, March 05, 2012
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies
Company announced the expansion of its microbiology portfolio to include new automated instrumentation technologies that will enable the Company to offer innovative total lab automation solutions to hospitals and laboratories worldwide.
Thursday, February 16, 2012
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Hepatitis C Virus Testing Guidelines Miss Too Many Cases
Urban emergency departments a good place to enact universal screening for adults.
NIH Sequences Genome of a Fungus
Researchers at the Institute have sequenced genome of human, mouse and rat Pneumocystis that cause life-threatening Pneumonia in immunosuppressed hosts.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!